Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

United Therapeutic (UTHR) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 5,365,070
  • Shares Outstanding, K 43,470
  • Annual Sales, $ 1,466 M
  • Annual Income, $ 652 M
  • 36-Month Beta 1.37
  • Price/Sales 3.66
  • Price/Book 2.99

Price Performance

See More
Period Period Low Period High Performance
1-Month
115.04 +16.05%
on 11/07/16
136.88 -2.47%
on 11/16/16
+19.37 (+16.97%)
since 11/04/16
3-Month
110.90 +20.38%
on 10/21/16
136.88 -2.47%
on 11/16/16
+11.04 (+9.01%)
since 09/06/16
52-Week
97.52 +36.90%
on 06/27/16
164.04 -18.61%
on 12/16/15
-25.29 (-15.93%)
since 12/04/15

Most Recent Stories

More News
J&J (JNJ) Reportedly Approaches Actelion for Acquisition

Reportedly, Johnson & Johnson (JNJ) recently approached Swiss biotechnology company, Actelion Ltd. (ALIOF), with a potential takeover offer.

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating United Therapeutics Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors

NEW YORK, NY / ACCESSWIRE / November 1, 2016 / Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of United Therapeutics Corporation -- UTHR

NEW YORK, NY / ACCESSWIRE / October 31, 2016 / Levi & Korsinsky announces it has commenced an investigation of United Therapeutics Corporation (NASDAQ: UTHR) concerning possible breaches of fiduciary duty...

United Therapeutics Rises 2.22% on Heavy Volume: Watch For Potential Pullback

United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $118.00 to a high of $121.46. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day...

Look for Shares of United Therapeutics to Potentially Pullback after Yesterday's 2.22% Rise

United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $118.00 to a high of $121.46. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating United Therapeutics Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors

Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of...

United Therapeutics (UTHR) Beats Q3 Earnings, Sales Miss

United Therapeutics Corporation (UTHR) reported adjusted earnings of $3.63 per share.

United Therapeutics Corporation Reports Third Quarter 2016 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2016.

Is a Surprise Coming for United Therapeutics (UTHR) This Earnings Season?

United Therapeutics (UTHR) looks poised to beat analyst estimates this earnings season, with a favourable Zacks Rank and an ESP in positive territory

Look for Shares of United Therapeutics to Potentially Rebound after Yesterday's 3.00% Sell Off

United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $111.11 to a high of $116.79. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

UTD THERAPEUTIC is a biotechnology company focused on combating cardiovascular, inflammatory, and infectious diseases with unique therapeutic products. These products include pharmaceuticals, arginine products and telemedicine services.

See More

Support & Resistance

2nd Resistance Point 133.11
1st Resistance Point 131.24
Last Price 133.57
1st Support Level 127.39
2nd Support Level 125.41

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.